Business Management

FDA Reviews Safety of Two HIV Drugs.
The Food and Drug Administration said Thursday recent data show patients taking HIV drugs from GlaxoSmithKline and Bristol-Myers Squibb may have increased risk of heart attack.

FDA said data pooled from a 33,000-patient study of HIV patients showed those taking Glaxo”s Ziagen and Bristol-Myers” Videx had a greater chance of heart attack than patients on other medications.

.